We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
TP53
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • TP53
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

TP53
Synonyms LFS1, p53
Gene descriptioni

Full gene name according to HGNC.

Tumor protein p53
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Cancer-related genes
Disease related genes
Human disease related genes
Plasma proteins
Potential drug targets
Transcription factors
Transporters
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 17
Cytoband p13.1
Chromosome location (bp) 7661779 - 7687538
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

23
Ensembl ENSG00000141510 (version 109)
Entrez gene 7157
HGNC HGNC:11998
UniProt P04637 (UniProt - Evidence at protein level)
neXtProt NX_P04637
GeneCards TP53
Antibodypedia TP53 antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression 30, 31. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 32. However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP 33. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 34.... show less
Molecular function (UniProt)i

Keywords assigned by UniProt to proteins due to their particular molecular function.

Activator, DNA-binding, Repressor
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation
Ligand (UniProt)i

Keywords assigned by UniProt to proteins because they bind, are associated with, or whose activity is dependent of some molecule.

Metal-binding, Zinc
Gene summary (Entrez)i

Useful information about the gene from Entrez

This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
TP53-201
ENSP00000269305
ENST00000269305
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
K7PPA8
[Target identity:100%; Query identity:100%] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000423 [mitophagy]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001701 [in utero embryonic development]
GO:0001756 [somitogenesis]
GO:0001836 [release of cytochrome c from mitochondria]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0002309 [T cell proliferation involved in immune response]
GO:0002326 [B cell lineage commitment]
GO:0002360 [T cell lineage commitment]
GO:0002931 [response to ischemia]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005657 [replication fork]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006302 [double-strand break repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006606 [protein import into nucleus]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006979 [response to oxidative stress]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007179 [transforming growth factor beta receptor signaling pathway]
GO:0007265 [Ras protein signal transduction]
GO:0007346 [regulation of mitotic cell cycle]
GO:0007369 [gastrulation]
GO:0007405 [neuroblast proliferation]
GO:0007406 [negative regulation of neuroblast proliferation]
GO:0007417 [central nervous system development]
GO:0007507 [heart development]
GO:0007623 [circadian rhythm]
GO:0008104 [protein localization]
GO:0008156 [negative regulation of DNA replication]
GO:0008270 [zinc ion binding]
GO:0008283 [cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0009303 [rRNA transcription]
GO:0009410 [response to xenobiotic stimulus]
GO:0009411 [response to UV]
GO:0009651 [response to salt stress]
GO:0009792 [embryo development ending in birth or egg hatching]
GO:0010035 [response to inorganic substance]
GO:0010165 [response to X-ray]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0010629 [negative regulation of gene expression]
GO:0010659 [cardiac muscle cell apoptotic process]
GO:0010666 [positive regulation of cardiac muscle cell apoptotic process]
GO:0012501 [programmed cell death]
GO:0014009 [glial cell proliferation]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019661 [glucose catabolic process to lactate via pyruvate]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0021549 [cerebellum development]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030512 [negative regulation of transforming growth factor beta receptor signaling pathway]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031065 [positive regulation of histone deacetylation]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033077 [T cell differentiation in thymus]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034103 [regulation of tissue remodeling]
GO:0034644 [cellular response to UV]
GO:0035033 [histone deacetylase regulator activity]
GO:0035035 [histone acetyltransferase binding]
GO:0035264 [multicellular organism growth]
GO:0035794 [positive regulation of mitochondrial membrane permeability]
GO:0035861 [site of double-strand break]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042127 [regulation of cell population proliferation]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043073 [germ cell nucleus]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043504 [mitochondrial DNA repair]
GO:0043516 [regulation of DNA damage response, signal transduction by p53 class mediator]
GO:0043523 [regulation of neuron apoptotic process]
GO:0043525 [positive regulation of neuron apoptotic process]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045861 [negative regulation of proteolysis]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045930 [negative regulation of mitotic cell cycle]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048144 [fibroblast proliferation]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0048568 [embryonic organ development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0050821 [protein stabilization]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051276 [chromosome organization]
GO:0051402 [neuron apoptotic process]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0060253 [negative regulation of glial cell proliferation]
GO:0060333 [type II interferon-mediated signaling pathway]
GO:0060411 [cardiac septum morphogenesis]
GO:0061419 [positive regulation of transcription from RNA polymerase II promoter in response to hypoxia]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0062100 [positive regulation of programmed necrotic cell death]
GO:0065003 [protein-containing complex assembly]
GO:0070059 [intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress]
GO:0070242 [thymocyte apoptotic process]
GO:0070243 [regulation of thymocyte apoptotic process]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0070266 [necroptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071494 [cellular response to UV-C]
GO:0071889 [14-3-3 protein binding]
GO:0072089 [stem cell proliferation]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072593 [reactive oxygen species metabolic process]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097371 [MDM2/MDM4 family protein binding]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1901525 [negative regulation of mitophagy]
GO:1902108 [regulation of mitochondrial membrane permeability involved in apoptotic process]
GO:1902253 [regulation of intrinsic apoptotic signaling pathway by p53 class mediator]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1903799 [negative regulation of miRNA maturation]
GO:1904024 [negative regulation of glucose catabolic process to lactate via pyruvate]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990144 [intrinsic apoptotic signaling pathway in response to hypoxia]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000269 [regulation of fibroblast apoptotic process]
GO:2000378 [negative regulation of reactive oxygen species metabolic process]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000647 [negative regulation of stem cell proliferation]
GO:2000772 [regulation of cellular senescence]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
393 aa
43.7 kDa
No 0
TP53-202
ENSP00000352610
ENST00000359597
J3KP33
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0046872 [metal ion binding]
GO:0048511 [rhythmic process]
Show all
343 aa
37.9 kDa
No 0
TP53-203
ENSP00000410739
ENST00000413465
E7EQX7
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0046872 [metal ion binding]
GO:0048511 [rhythmic process]
Show all
285 aa
31.5 kDa
No 0
TP53-204
ENSP00000391127
ENST00000420246
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
341 aa
37.8 kDa
No 0
TP53-205
ENSP00000391478
ENST00000445888
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
K7PPA8
[Target identity:100%; Query identity:100%] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
393 aa
43.7 kDa
No 0
TP53-206
ENSP00000398846
ENST00000455263
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
346 aa
38.5 kDa
No 0
TP53-207
ENSP00000426252
ENST00000503591
E9PCY9
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005829 [cytosol]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0048511 [rhythmic process]
Show all
127 aa
13.6 kDa
No 0
TP53-208
ENSP00000484409
ENST00000504290
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
214 aa
24.4 kDa
No 0
TP53-209
ENSP00000481179
ENST00000504937
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
261 aa
29.6 kDa
No 0
TP53-211
ENSP00000424104
ENST00000508793
E7EMR6
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0046872 [metal ion binding]
GO:0048511 [rhythmic process]
Show all
165 aa
17.8 kDa
No 0
TP53-212
ENSP00000425104
ENST00000509690
E7ESS1
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0046872 [metal ion binding]
Show all
199 aa
22.5 kDa
No 0
TP53-213
ENSP00000478499
ENST00000510385
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
209 aa
23.7 kDa
No 0
TP53-214
ENSP00000423862
ENST00000514944
E9PFT5
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005815 [microtubule organizing center]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0046872 [metal ion binding]
GO:0048511 [rhythmic process]
Show all
155 aa
17.7 kDa
No 0
TP53-217
ENSP00000458393
ENST00000576024
I3L0W9
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
31 aa
3.4 kDa
No 0
TP53-218
ENSP00000473895
ENST00000604348
S4R334
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0012501 [programmed cell death]
GO:0016605 [PML body]
GO:0048511 [rhythmic process]
Show all
143 aa
15.4 kDa
No 0
TP53-219
ENSP00000478219
ENST00000610292
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
H2EHT1
[Target identity:100%; Query identity:100%] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
354 aa
39.3 kDa
No 0
TP53-220
ENSP00000480868
ENST00000610538
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
307 aa
34.2 kDa
No 0
TP53-221
ENSP00000477531
ENST00000610623
A0A087WT22
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0046872 [metal ion binding]
Show all
187 aa
21.4 kDa
No 0
TP53-222
ENSP00000481401
ENST00000618944
A0A087WXZ1
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0046872 [metal ion binding]
Show all
182 aa
20.7 kDa
No 0
TP53-223
ENSP00000484375
ENST00000619186
A0A087X1Q1
[Direct mapping] Cellular tumor antigen p53
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000976 [transcription cis-regulatory region binding]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006915 [apoptotic process]
GO:0007049 [cell cycle]
GO:0046872 [metal ion binding]
GO:0051262 [protein tetramerization]
Show all
234 aa
26.6 kDa
No 0
TP53-224
ENSP00000482537
ENST00000619485
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
H2EHT1
[Target identity:100%; Query identity:100%] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
354 aa
39.3 kDa
No 0
TP53-225
ENSP00000481638
ENST00000620739
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
H2EHT1
[Target identity:100%; Query identity:100%] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
354 aa
39.3 kDa
No 0
TP53-226
ENSP00000482222
ENST00000622645
P04637
[Direct mapping] Cellular tumor antigen p53
Show all
Transporters
   Transporter channels and pores
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Immunoglobulin fold
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
   COSMIC Translocations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the lung and pleura
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of eye, brain, and central nervous system
   Cancers of endocrine organs
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
   Musculoskeletal diseases
   Skeletal diseases
   Nervous system diseases
   Other nervous and sensory system diseases
   Other diseases
   Others
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001046 [core promoter sequence-specific DNA binding]
GO:0001094 [TFIID-class transcription factor complex binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002020 [protease binding]
GO:0002039 [p53 binding]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0003730 [mRNA 3'-UTR binding]
GO:0005507 [copper ion binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005783 [endoplasmic reticulum]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006289 [nucleotide-excision repair]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006914 [autophagy]
GO:0006915 [apoptotic process]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0006977 [DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest]
GO:0006978 [DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator]
GO:0006983 [ER overload response]
GO:0007049 [cell cycle]
GO:0007265 [Ras protein signal transduction]
GO:0008104 [protein localization]
GO:0008270 [zinc ion binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0008340 [determination of adult lifespan]
GO:0009299 [mRNA transcription]
GO:0010332 [response to gamma radiation]
GO:0010628 [positive regulation of gene expression]
GO:0012501 [programmed cell death]
GO:0016032 [viral process]
GO:0016363 [nuclear matrix]
GO:0016604 [nuclear body]
GO:0016605 [PML body]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0019903 [protein phosphatase binding]
GO:0030308 [negative regulation of cell growth]
GO:0030330 [DNA damage response, signal transduction by p53 class mediator]
GO:0030971 [receptor tyrosine kinase binding]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031625 [ubiquitin protein ligase binding]
GO:0032991 [protein-containing complex]
GO:0033209 [tumor necrosis factor-mediated signaling pathway]
GO:0034644 [cellular response to UV]
GO:0035035 [histone acetyltransferase binding]
GO:0036003 [positive regulation of transcription from RNA polymerase II promoter in response to stress]
GO:0036310 [ATP-dependent DNA/DNA annealing activity]
GO:0042149 [cellular response to glucose starvation]
GO:0042771 [intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator]
GO:0042802 [identical protein binding]
GO:0042826 [histone deacetylase binding]
GO:0042981 [regulation of apoptotic process]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043153 [entrainment of circadian clock by photoperiod]
GO:0043621 [protein self-association]
GO:0045815 [transcriptional initiation-coupled chromatin remodeling]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045899 [positive regulation of RNA polymerase II transcription preinitiation complex assembly]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0046872 [metal ion binding]
GO:0046982 [protein heterodimerization activity]
GO:0047485 [protein N-terminus binding]
GO:0048147 [negative regulation of fibroblast proliferation]
GO:0048511 [rhythmic process]
GO:0048512 [circadian behavior]
GO:0048539 [bone marrow development]
GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation]
GO:0051087 [chaperone binding]
GO:0051097 [negative regulation of helicase activity]
GO:0051262 [protein tetramerization]
GO:0051721 [protein phosphatase 2A binding]
GO:0051726 [regulation of cell cycle]
GO:0051974 [negative regulation of telomerase activity]
GO:0060218 [hematopoietic stem cell differentiation]
GO:0061629 [RNA polymerase II-specific DNA-binding transcription factor binding]
GO:0065003 [protein-containing complex assembly]
GO:0070245 [positive regulation of thymocyte apoptotic process]
GO:0071456 [cellular response to hypoxia]
GO:0071466 [cellular response to xenobiotic stimulus]
GO:0071479 [cellular response to ionizing radiation]
GO:0071480 [cellular response to gamma radiation]
GO:0071889 [14-3-3 protein binding]
GO:0072331 [signal transduction by p53 class mediator]
GO:0072332 [intrinsic apoptotic signaling pathway by p53 class mediator]
GO:0072717 [cellular response to actinomycin D]
GO:0090200 [positive regulation of release of cytochrome c from mitochondria]
GO:0090398 [cellular senescence]
GO:0090399 [replicative senescence]
GO:0090403 [oxidative stress-induced premature senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0097252 [oligodendrocyte apoptotic process]
GO:0097718 [disordered domain specific binding]
GO:0140296 [general transcription initiation factor binding]
GO:0140677 [molecular function activator activity]
GO:1900119 [positive regulation of execution phase of apoptosis]
GO:1902749 [regulation of cell cycle G2/M phase transition]
GO:1902895 [positive regulation of miRNA transcription]
GO:1903451 [negative regulation of G1 to G0 transition]
GO:1905856 [negative regulation of pentose-phosphate shunt]
GO:1990248 [regulation of transcription from RNA polymerase II promoter in response to DNA damage]
GO:1990440 [positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress]
GO:1990841 [promoter-specific chromatin binding]
GO:2000379 [positive regulation of reactive oxygen species metabolic process]
GO:2000774 [positive regulation of cellular senescence]
GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Show all
302 aa
33.5 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org